Cargando…
Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID‐19
Confronting the challenge of the outbreak of COVID‐19 should sharpen our focus on global drug access as a key issue in antiviral therapy testing. The testing and adoption of effective therapies for novel coronaviruses are hampered by the challenge of conducting controlled studies during a state of e...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228408/ https://www.ncbi.nlm.nih.gov/pubmed/32227493 http://dx.doi.org/10.1002/jmv.25798 |